PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Deletion of any single gene provokes mutations elsewhere in the genome

Findings call for a rethinking of cancer genetics

2013-11-14
(Press-News.org) Contact information: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine
Deletion of any single gene provokes mutations elsewhere in the genome Findings call for a rethinking of cancer genetics

Johns Hopkins researchers report that the deletion of any single gene in yeast cells puts pressure on the organism's genome to compensate, leading to a mutation in another gene. Their discovery, which is likely applicable to human genetics because of the way DNA is conserved across species, could have significant consequences for the way genetic analysis is done in cancer and other areas of research, they say.

Summarized in a report to be published on Nov. 21 in the journal Molecular Cell, the team's results add new evidence that genomes, the sum total of species' genes, are like supremely intricate machines, in that the removal of a single, tiny part stresses the whole mechanism and might cause another part to warp elsewhere to fill in for the missing part.

"The deletion of any given gene usually results in one, or sometimes two, specific genes being 'warped' in response," says J. Marie Hardwick, Ph.D., the David Bodian Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health and a professor of pharmacology and molecular sciences at the school of medicine. "Pairing the originally deleted gene with the gene that was secondarily mutated gave us a list of gene interactions that were largely unknown before."

Hardwick says the findings call researchers to greater scrutiny in their genetic analyses because they could unwittingly attribute a phenomenon to a gene they mutated, when it is actually due to a secondary mutation.

"This work has the potential to transform the field of cancer genetics," Hardwick says. "We had been thinking of cancer as progressing from an initial mutation in a tumor-suppressor gene, followed by additional mutations that help the cancer thrive. Our work provides hard evidence that a single one of those 'additional mutations' might come first and actively provoke the mutations seen in tumor-suppressor genes. We hope that our findings in yeast will help to identify these 'first' mutations in tumors."

The beauty of working with yeast, Hardwick says, is that it is easy to delete, or "knock out," any given gene. Her team started with a readily available collection of thousands of different yeast strains, each with a different gene knockout.

At their preferred temperature, each of these strains of yeast grows robustly even though they each have a different gene missing. Hardwick's team first asked a fundamental question: Within a given strain of yeast, does each cell have the same genetic sequence as the other cells, as had generally been presumed?

"We know, for example, that within a given tumor, different cells have different mutations or versions of a gene," explains Hardwick. "So it seemed plausible that other cell populations would exhibit a similar genetic diversity."

To test this idea, her team randomly chose 250 single-knockout strains from the thousands of strains in the collection. For each strain, they generated six sub-strains, each derived from a single yeast cell from the "parental batch."

They then put each sub-strain through a "stress test" designed to detect sub-strains with behaviors that varied from the behavior of the parental batch. All of the sub-strains grew indistinguishably without stress, but when the temperature was gradually raised for only a few minutes, some sub-strains died because they could not handle the stress. When the Hardwick team examined their genes, they found that, in addition to the originally knocked-out gene, each of the sub-strains that faltered also had a mutation in another gene, leading the team to conclude that the cells in each strain of the single-gene knockouts do not all share the same genetic sequence.

They then tested all 5,000 of the original single-gene knockout strains to find sub-strains that could overgrow when given low-nutrient food — a trait that tumor cells often possess. This was another stress test designed to detect differences between the individual cells taken from the parental batches. They identified 749 such knockout strains and showed that their growth differences were often due to secondary mutations.

In total, the team's evidence indicates that 77 percent of all the knockout strains have acquired one or two additional mutations that affect cell survival and/or excessive growth when food is scarce.

Hardwick believes that stressing yeast in other ways may lead to an even higher percentage of double-mutant strains. In fact, she said she believes that "essentially any gene, when mutated, has the power to alter other genes in the genome." Deleting the first gene seems to cause a biological imbalance that is sufficient to provoke additional adaptive genetic changes, she explains.

Furthermore, in all of the strains that they examined, they found that the secondary mutations that appeared after a given knockout were always in the same one or two genes as in their earlier observations. Unexpectedly, Hardwick said, the altered growth of the sub-strains was usually due to the secondary mutations, not the original knockout, and many of those secondary mutations were in genes that are known to be cancer-causing in humans.



INFORMATION:



Other authors of the report include Xinchen Teng, Catherine Gilbert, Sarah Wheelan, Jef Boeke and Fernando Pineda of the Johns Hopkins University School of Medicine, and Margaret Dayhoff-Brannigan, Wen-Chih Cheng, Cierra Sing and Nicola Diny of the Johns Hopkins University Bloomberg School of Public Health and Maitreya Dunham of the University of Washington, Seattle.

This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS083373, NS037402) and the National Institute of General Medical Sciences (GM077875, P50-GM071508, U54 GM103520).

On the Web:

Link to article: http://dx.doi.org/10.1016/j.molcel.2013.09.026

Hardwick Lab: http://www.hopkinsmedicine.org/pharmacology_molecular_sciences/faculty/bios/hardwick.html

Johns Hopkins Medicine
Media Relations and Public Affairs

Media Contacts:

Catherine Kolf; 443-287-2251; ckolf@jhmi.edu

Tim Parsons; 410-955-6878; tmparson@jhsph.edu

Vanessa McMains; 410-502-9410; vmcmain1@jhmi.edu



ELSE PRESS RELEASES FROM THIS DATE:

Gene linked to common intellectual disability

2013-11-14
Gene linked to common intellectual disability University of Adelaide researchers have taken a step forward in unravelling the causes of a commonly inherited intellectual disability, finding that a genetic mutation leads to a reduction in certain ...

Fossil of new big cat species discovered; oldest ever found

2013-11-14
Fossil of new big cat species discovered; oldest ever found 4-million-year-old skull of relative of snow leopard fleshes out fossil record of big cats and challenges suppositions about how and where they evolved The oldest big cat fossil ever found – ...

Rapid testing to diagnose influenza leads to more appropriate care in the ED

2013-11-14
Rapid testing to diagnose influenza leads to more appropriate care in the ED When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral ...

Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both

2013-11-14
Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both WASHINGTON — A molecule that helps cells stick together is significantly over-produced in two very different diseases — rheumatoid arthritis and a variety of cancers, including ...

Primary care key to management of patients with HIV infection

2013-11-14
Primary care key to management of patients with HIV infection Updated HIVMA Guidelines indicate doctors should focus on common health conditions [EMBARGOED FOR NOV. 14, 2013, ARLINGTON, Va.] – The HIV Medicine Association (HIVMA) of the Infectious Diseases ...

Accidental discovery dramatically improves electrical conductivity

2013-11-14
Accidental discovery dramatically improves electrical conductivity Crystal could improve performance of electronic devices PULLMAN, Wash.—Quite by accident, Washington State University researchers have achieved a 400-fold increase in the electrical conductivity ...

Using airport screening technology to visualize waves in fusion plasma

2013-11-13
Using airport screening technology to visualize waves in fusion plasma Millimeter-wave imaging helps scientists better understand and manage plasma instabilities Millimeter-wave imaging technology is widely used in airborne radar, automotive sensors and full-body ...

New links between social status and brain activity

2013-11-13
New links between social status and brain activity Social stability affects the production of new brain cells; ability of brain to adapt is key to coping with hierarchies and stress SAN DIEGO — New studies released today reveal links between social status and specific ...

Can the eyes help diagnose Alzheimer's disease?

2013-11-13
Can the eyes help diagnose Alzheimer's disease? VIDEO: Scott Turner, M.D., Ph.D., discusses research to be presented at the Neuroscience 2013 meeting. He and an ...

Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics

2013-11-13
Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics Groundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition Arlington, Va. — A novel hand-held, noninvasive monitoring device that uses ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Deletion of any single gene provokes mutations elsewhere in the genome
Findings call for a rethinking of cancer genetics